Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03074903 · ClinicalTrials.gov registry record
Does Skyla Insertion Timing Impact Bleeding?
A clinical trial of Vaginal Bleeding, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- 132
- Enrollment target
- 3
- Study locations
NCT03074903: Completed study of Vaginal Bleeding, sponsored by Rutgers, The State University of New Jersey.
NCT03074903 is a study of Vaginal Bleeding that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 132 participants. The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03074903, a study of Vaginal Bleeding, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- 132 participants
- Enrollment target
- 3
- Study locations
Study Summary
Women presenting for contraception will be offered the IUS Skyla and study participation. Daily bleeding will be collected for a total of 90 days and correlated with insertion timing and baseline endometrial thickness.
Primary Outcome
Composite variable of bleeding and spotting for 90 days after Skyla IUS insertion
Conditions Studied
Interventions
- DEVICE Intrauterine system
Study Locations (3)
New Jersey
- Planned Parenthood - Morristown
- NJFPC - Newark
- SHS - Newark
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 132 participants |
| Start Date | 2016-04-16 |
| Est. Completion | 2017-07-28 |
What the finished NCT03074903 record still lists
NCT03074903 is an observational study that tracks outcomes without assigning an intervention. The registered 132 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Vaginal Bleeding appearing as the primary indexed condition, and to 1 intervention - of which Intrauterine system is the first listed.
NCT03074903 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT03074903 about?
NCT03074903 is a clinical study titled "Does Skyla Insertion Timing Impact Bleeding?". Women presenting for contraception will be offered the IUS Skyla and study participation. Daily bleeding will be collected for a total of 90 days and correlated with insertion timing and baseline endometrial thickness.
What is the current status of trial NCT03074903?
This trial is currently completed. The enrollment target is 132 participants. The study started on 2016-04-16. Estimated completion is 2017-07-28.
What conditions does trial NCT03074903 study?
This clinical trial studies the following conditions: Vaginal Bleeding.
What interventions are being tested in trial NCT03074903?
The interventions under investigation include: Intrauterine system (DEVICE).
Who is sponsoring clinical trial NCT03074903?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03074903 being conducted?
This trial has 3 study locations across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vaginal Bleeding
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01766297 · 132 participants · Phase 2
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
- NCT04002947 · 132 participants · Phase 2
Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma
- NCT04128189 · 132 participants · Phase 3
Shingrix in Renal Transplant Recipients
- NCT04199780 · 132 participants · NA
Effects of tDCS Combined With CBI on Postsurgical Pain
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI